Linking Disease Mechanisms and Outcomes in Rheumatic Diseases

将风湿性疾病的疾病机制和结果联系起来

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT Mentorship has been identified as a critical facilitator for development of clinical research faculty. This K24 application seeks to provide protected time for the applicant to continue to mentor numerous trainees in patient- oriented research (POR) and to grow her current program in new directions to further expand opportunities to mentor in this arena. 30% of the applicant's effort will be protected by this award for these activities. The applicant has demonstrated significant abilities in mentoring trainees at all career stages and will continue to benefit from the rich and robust institutional environment that provides stellar research infrastructure and a large pool of patients and mentees to work with. During the funding period, further development of the applicant will include 1) Improvement in mentorship skills in POR; 2) Enhancement of biostatistics for POR; and 3) Construction of a collaborative niche for POR in pain in rheumatic disease. These skillsets will be achieved through a combination of seminars, meetings, courses, and collaboration with the U of M Chronic Pain and Fatigue Research Center and the U of M Fibromyalgia Center of Research Translation (CORT). In addition, these skillsets will integrate and grow through continued mentorship of trainees within currently funded POR and through expansion into pain research through the K24 mechanism. These research opportunities include: work that examines the biology of lupus skin in the context of patient presentation and disease phenotype (Project 1); A clinical trial examining the impact of microbial colonization on lupus skin inflammation (Project 2); A large, novel immunophenotyped cohort of lupus and psoriasis/psoriatic arthritis patients that provides large scale datasets for analysis and clinical correlation (Project 3) and; A new dataset collected to longitudinally map chronic pain and sensory sensitivity in patients with systemic lupus (Project 4). Successful completion of this award will result in successful mentoring of current and future mentees in POR and also enlarge the POR program of the applicant to ensure continued mentoring opportunities into the future.
项目概要/摘要 导师制已被认为是临床研究人员发展的关键促进因素。这个K24 申请旨在为申请人提供受保护的时间,以继续指导众多患者的实习生 定向研究(POR),并将她当前的项目向新的方向发展,以进一步扩大机会 这个领域的导师。申请人在这些活动中 30% 的努力将受到该奖项的保护。申请人 在指导各个职业阶段的学员方面表现出了卓越的能力,并将继续受益于 丰富而强大的制度环境,提供一流的研究基础设施和大量的人才 与患者和受训者一起工作。 在资助期间,申请人的进一步发展将包括1)指导技能的提高 在 POR 中; 2)加强POR的生物统计; 3) 构建疼痛中 POR 的协作利基 在风湿性疾病中。这些技能将通过研讨会、会议、课程、 以及与密歇根大学慢性疼痛和疲劳研究中心以及密歇根大学纤维肌痛中心的合作 of Research Translation (CORT).此外,这些技能将通过持续的整合和发展 在目前资助的 POR 中对学员进行指导,并通过 K24 扩展到疼痛研究 机制。这些研究机会包括: 在背景下检查狼疮皮肤生物学的工作 患者表现和疾病表型(项目 1);一项检验微生物影响的临床试验 狼疮皮肤炎症的定植(项目 2);一个大型的、新型的狼疮和免疫表型队列 银屑病/银屑病关节炎患者提供大规模数据集用于分析和临床相关性(项目 3) 和;收集的新数据集用于纵向绘制患有以下疾病的患者的慢性疼痛和感觉敏感性 系统性狼疮(项目 4)。成功完成该奖项将导致成功指导当前和 未来的 POR 受训者,并扩大申请人的 POR 计划,以确保持续指导 未来的机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joanne Michelle Kahlenberg其他文献

Joanne Michelle Kahlenberg的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joanne Michelle Kahlenberg', 18)}}的其他基金

Hippo signaling as a critical regulator of lupus keratinocyte dysfunction
Hippo 信号作为狼疮角质形成细胞功能障碍的关键调节因子
  • 批准号:
    10675692
  • 财政年份:
    2022
  • 资助金额:
    $ 13.5万
  • 项目类别:
Hippo signaling as a critical regulator of lupus keratinocyte dysfunction
Hippo 信号作为狼疮角质形成细胞功能障碍的关键调节因子
  • 批准号:
    10536347
  • 财政年份:
    2022
  • 资助金额:
    $ 13.5万
  • 项目类别:
Linking Disease Mechanisms and Outcomes in Rheumatic Diseases
将风湿性疾病的疾病机制和结果联系起来
  • 批准号:
    10657643
  • 财政年份:
    2020
  • 资助金额:
    $ 13.5万
  • 项目类别:
Linking Disease Mechanisms and Outcomes in Rheumatic Diseases
将风湿性疾病的疾病机制和结果联系起来
  • 批准号:
    10210191
  • 财政年份:
    2020
  • 资助金额:
    $ 13.5万
  • 项目类别:
Characterization of Interferon Kappa as a Novel Target in Cutaneous Lupus
干扰素 Kappa 作为皮肤狼疮新靶点的表征
  • 批准号:
    9761987
  • 财政年份:
    2017
  • 资助金额:
    $ 13.5万
  • 项目类别:
Characterization of Interferon Kappa as a Novel Target in Cutaneous Lupus
干扰素 Kappa 作为皮肤狼疮新靶点的表征
  • 批准号:
    10238899
  • 财政年份:
    2017
  • 资助金额:
    $ 13.5万
  • 项目类别:
Characterization of Interferon Kappa as a Novel Target in Cutaneous Lupus
干扰素 Kappa 作为皮肤狼疮新靶点的表征
  • 批准号:
    10470213
  • 财政年份:
    2017
  • 资助金额:
    $ 13.5万
  • 项目类别:
Characterization of Interferon Kappa as a Novel Target in Cutaneous Lupus
干扰素 Kappa 作为皮肤狼疮新靶点的表征
  • 批准号:
    10004499
  • 财政年份:
    2017
  • 资助金额:
    $ 13.5万
  • 项目类别:
Identification of BATF2 as a Regulator of Interferon-Enhanced Inflammatory Responses in Lupus Skin
鉴定 BATF2 作为狼疮皮肤中干扰素增强炎症反应的调节剂
  • 批准号:
    9375222
  • 财政年份:
    2017
  • 资助金额:
    $ 13.5万
  • 项目类别:
Understanding transcriptional connections between cutaneous and systemic lupus
了解皮肤狼疮和系统性狼疮之间的转录联系
  • 批准号:
    8825016
  • 财政年份:
    2014
  • 资助金额:
    $ 13.5万
  • 项目类别:

相似国自然基金

Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
  • 批准号:
    31171277
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

Study of Neuropilin-1 as a potential marker of self-reactive Th cells in autoimmune neuroinflammation
Neuropilin-1 作为自身免疫性神经炎症中自身反应性 Th 细胞潜在标志物的研究
  • 批准号:
    24K10278
  • 财政年份:
    2024
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Shared and distinct genetic architecture of autoimmune and hormonal alopecias
自身免疫性脱发和激素性脱发的共同和独特的遗传结构
  • 批准号:
    MR/X030466/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Research Grant
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
  • 批准号:
    479128
  • 财政年份:
    2023
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Operating Grants
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
  • 批准号:
    493526
  • 财政年份:
    2023
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Operating Grants
Environmental factors and risk of autoimmune rheumatic disease incidence and serology
环境因素和自身免疫性风湿病发病率和血清学的风险
  • 批准号:
    498306
  • 财政年份:
    2023
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Operating Grants
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
  • 批准号:
    23H02155
  • 财政年份:
    2023
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
PTSD and Autoimmune Disease: Towards Causal Effects, Risk Factors, and Mitigators
创伤后应激障碍 (PTSD) 和自身免疫性疾病:因果效应、危险因素和缓解措施
  • 批准号:
    10696671
  • 财政年份:
    2023
  • 资助金额:
    $ 13.5万
  • 项目类别:
Build to LEAD – Building partnerships to Link the Exposome to Autoimmune Disease
构建引领 — 建立合作伙伴关系,将暴露组与自身免疫性疾病联系起来
  • 批准号:
    10871040
  • 财政年份:
    2023
  • 资助金额:
    $ 13.5万
  • 项目类别:
Functional consequences of intergenic autoimmune disease risk variants
基因间自身免疫性疾病风险变异的功能后果
  • 批准号:
    10655161
  • 财政年份:
    2023
  • 资助金额:
    $ 13.5万
  • 项目类别:
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
  • 批准号:
    10788032
  • 财政年份:
    2023
  • 资助金额:
    $ 13.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了